Breakout Ventures Launches Fund III with $114M to Continue Building the Future Powered by Science [Yahoo! Finance]
Halozyme Therapeutics, Inc. (HALO)
Last halozyme therapeutics, inc. earnings: 2/24 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
halozyme.com/investors/default.aspx
Company Research
Source: Yahoo! Finance
Breakout Ventures Launches Fund III Fund III is actively being deployed, with three new seed investments in founder-led companies unlocking the complexity of science with AI. Fund II portfolio company Surf Bio recently announced its acquisition by Halozyme (HALO) for up to $400M. SAN FRANCISCO, March 10, 2026 BUSINESS WIRE )--Breakout Ventures today announced the close of its $114M Fund III. Since its launch in 2016, Breakout Ventures has partnered with exceptional founders to scale scientific innovation and build breakout companies. Given Breakout's ongoing success, the new fund received strong support from returning investors including Cortes Capital, S-Cubed Capital, The Kraft Group, Pinegrove Venture Partners, and an affiliate of LH Capital, and is pleased to add new limited partners including JIMCO, the global investment arm of the Jameel family, and Korea Omega Investment Corporation. With the launch of this new fund, Managing Partner Lindy Fishburne said, "We've spent
Show less
Read more
Impact Snapshot
Event Time:
HALO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HALO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HALO alerts
High impacting Halozyme Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
HALO
News
- Halozyme Therapeutics Touts $1.8B Revenue Outlook, ENHANZE Royalties and New Hypercon Deals at Conference [Yahoo! Finance]Yahoo! Finance
- Halozyme Names Interim CFO As Investors Weigh Valuation And Recent Weakness [Yahoo! Finance]Yahoo! Finance
- Halozyme Appoints David Ramsay as Interim Chief Financial Officer [Yahoo! Finance]Yahoo! Finance
- Halozyme Appoints David Ramsay as Interim Chief Financial OfficerPR Newswire
- Halozyme Therapeutics, Inc. (HALO) Presents at The Citizens Life Sciences Conference 2026 Transcript [Seeking Alpha]Seeking Alpha
HALO
Earnings
- 2/17/26 - Miss
HALO
Sec Filings
- 3/12/26 - Form 8-K
- 3/10/26 - Form 4
- 3/10/26 - Form 144
- HALO's page on the SEC website